RICHTON KATHLEEN P. enters ENGENE THERAPEUTICS INC. with 6.90K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/22/2026ACC: 0000929638-26-002666
Officer· SVP, Finance and Treasurer
Since Jul 2026
6.90K
Baseline shares
100% direct
6.90K
Direct ownership
1 position
163.90K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned6.90K
Total
6.90K direct6.90K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 6.90K | Direct |
| Total | 6.90K | 6.90K direct |
Derivative Holdings3
Stock Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
45K
Shares owned
N/A
Exercise price
7.39
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
13.90K
Shares owned
N/A
Exercise price
9.53
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
105K
Shares owned
N/A
Exercise price
1.75
Expiration
—
Exercise window
—
Total
Underlying
163.90K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares | 7.39 | — | — | 45K | N/A |
| Stock Option (Right to Buy) Direct | Common Shares | 9.53 | — | — | 13.90K | N/A |
| Stock Option (Right to Buy) Direct | Common Shares | 1.75 | — | — | 105K | N/A |
| Total | 163.90K | 0.00 | ||||